Geistlich pharma enters Indian market



Expanding healthcare services, Swiss medical products firm Geistlich Pharma AG has announced the availability of its two globally patented products, Bio-Oss and Bio-Gide used for dental regeneration around the world, will now be available across India. Geistlich Bio-Oss and Geistlich Bio-Gide function as a clinical solution for bone regeneration and oral tissue regeneration, respectively.

Commenting on the development, Geistlich Pharma AG CEO Paul Note said, Our products supplement the patients complete dentistry-care requirements. In addition, we view India as a strategic fit for our business growth worldwide.

At present, it is only dental and only regenerative products in India, he added.


As per made statement, Company is also looking forward to register more products this year in India, if received permission from Indian regulatory bodies.

The company in future can also think of orthopaedics, sports medicine and hemostatic products space in India. But this is for the future, Note said.

This is a new chapter in Indian dentistry, where the Indian people will now be aware of regenerative bio-material and the benefits they offer, Geistlich Pharma India GM Sandeep Ghavri said.

Geistlich Pharma AG develops, manufactures and markets medical products for restoring bone, cartilage and soft tissues as well as drugs. The company currently provides its patented technology for dental regeneration biomaterials in over 90 countries.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top